ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,298Medicare Part D Prescriptions Filled, Including Refills

Rank: 94 out of 2588

$814K Total Retail Price of All Prescriptions

Rank: 153 out of 2588

636 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 636 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

19% of this provider’s 636 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 15,764 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LISINOPRIL 689 634 1 3
LEVOTHYROXINE SODIUM 616 580 2 2
FUROSEMIDE 571 549 3 5
SIMVASTATIN 561 520 4 1
OMEPRAZOLE 555 511 5 6
HYDROCODONE-ACETAMINOPHEN 552 451 S3 6 7
AMLODIPINE BESYLATE 473 433 7 4
METOPROLOL TARTRATE 406 385 8 9
WARFARIN SODIUM 319 296 9 10
METFORMIN HCL 315 271 10 8
TRAMADOL HCL 312 303 11 19
POTASSIUM CHLORIDE 308 294 12 15
ATENOLOL 300 273 13 14
TRIAMTERENE-HCTZ 257 244 14 46
GABAPENTIN 253 224 15 18
LOSARTAN POTASSIUM 253 248 15 17
DONEPEZIL HCL 243 243 17 22
CARVEDILOL 241 227 18 20
PRAVASTATIN SODIUM 210 206 19 16
ATORVASTATIN CALCIUM 191 165 20 11
SERTRALINE HCL 176 166 21 26
METOPROLOL SUCCINATE 169 166 22 12
RANITIDINE HCL 168 146 23 37
HYDROCHLOROTHIAZIDE 168 146 23 13
MIRTAZAPINE 158 158 25 63
PREDNISONE 155 145 26 42
PAROXETINE HCL 150 129 27 71
KLOR-CON M20 150 150 27 52
LOVASTATIN 149 139 29 34
ALLOPURINOL 140 138 30 33
TORSEMIDE 136 124 31 133
NEXIUM 130 126 32 41
FLUTICASONE PROPIONATE 127 120 33 40
OXYBUTYNIN CHLORIDE ER 126 114 34 85
ZOLPIDEM TARTRATE 121 115 35 24
PANTOPRAZOLE SODIUM 119 107 36 28
CRESTOR 112 101 37 25
CIPROFLOXACIN HCL 111 108 38 82
ALENDRONATE SODIUM 111 109 38 21
CLOPIDOGREL 108 101 40 30
POLYETHYLENE GLYCOL 3350 105 90 41 55
ADVAIR DISKUS 104 104 42 48
NAMENDA 96 96 43 32
AZITHROMYCIN 95 83 44 45
FLUOXETINE HCL 95 69 44 92
DIOVAN 95 95 44 29
CARBIDOPA-LEVODOPA 94 88 47 83
ISOSORBIDE MONONITRATE ER 93 93 48 49
GLIPIZIDE ER 93 93 48 73
ENALAPRIL MALEATE 92 83 50 31
TERAZOSIN HCL 91 76 51 137
DIGOXIN 90 87 52 38
MELOXICAM 88 74 53 51
DILTIAZEM 24HR CD 88 88 53 98
GLYBURIDE 86 77 R 55 65
PLAVIX 85 79 56 43
ACETAMINOPHEN-CODEINE 82 60 S3 57 80
KLOR-CON 10 81 78 58 75
OXYBUTYNIN CHLORIDE 79 70 59 132
HYDRALAZINE HCL 78 78 60 53
TRAZODONE HCL 78 45 60 61
CLONIDINE HCL 78 72 60 54
SPIRONOLACTONE 77 62 63 58
SPIRIVA 75 75 64 56
CITALOPRAM HBR 75 63 64 27
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 56 66 127
GLIPIZIDE 66 52 67 44
DILTIAZEM HCL 64 64 68 228
TAMSULOSIN HCL 62 53 69 23
AMITRIPTYLINE HCL 62 60 R 69 91
SYNTHROID 59 53 71 88
FENTANYL 58 58 S2 72 78
QUETIAPINE FUMARATE 56 56 73 74
FAMOTIDINE 55 37 74 36
NYSTOP 55 55 74 242
ENABLEX 55 50 74 304
LEVOFLOXACIN 55 51 74 77
ESCITALOPRAM OXALATE 54 53 78 68
DILTIAZEM 24HR ER 54 54 78 166
VERAPAMIL ER 53 49 80 102
ROPINIROLE HCL 53 53 80 113
CELEBREX 51 51 82 99
CYMBALTA 50 25 83 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.